Predicting survival after brain metastases in patients with bladder cancer
Önder, T., Karaçin, C., Kekilli, E., Göksel, F., Sertesen, E., Onur, İ. Deliktaş, Ateş, Ö., Yıldız, F., Arslan, Ü.Y
Published in Journal of clinical neuroscience (01.07.2024)
Published in Journal of clinical neuroscience (01.07.2024)
Get full text
Journal Article
288P Prognostic factors in nonmetastatic HER2 ‘low’ & HER2 ‘negative’ breast cancer: Single institute experience
Türkel, A., Dogan, M., Sertesen, E., Karacin, C., Irkkan, S.Ç., Ates, O.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
68P Real-world clinical and treatment-related outcomes in specific subgroups of patients with BRAF-positive metastatic melanoma treated with dabrafenib-trametinib: Turkish Oncology Group study
Yildirim, E. Caliskan, Semiz, H.S., Akyildiz, A., Yaslikaya, S., Sanci, P. Can, Guliyev, M., Sertesen, E., Akdag, G., Ozcan, E., Mecidova, N., Ugrakli, M., Demirci, N.S., Kefeli, U., Paydas, S., Ates, O., Cicin, I., Yildirim, M.E., Dizdar, O., Celik, I., Karaoglu, A.
Published in ESMO open (01.02.2024)
Published in ESMO open (01.02.2024)
Get full text
Journal Article